Pathology Diagnostics Ltd – a key component of your drug and biomarker development team

We specialise in the provision of clinical diagnostics and quantitative image analysis on human tissues for studies ranging from early discovery to clinical trials

Pathology Diagnostics Ltd – a key component of your drug and biomarker development team

Quality control is key

We hold key industry accreditations so that you can be assured that our results are accurate, reliable and consistent

Quality control is key

Expert people

Our team of expert pathologists and trained scientists provides a unique breadth of scientific and diagnostics experience

Expert people

Distinctive strengths

We pride ourselves in understanding your project needs by providing high-quality, consistent and reliable results on time, enabling you to make informed data-driven decisions

Distinctive strengths

Transforming pathology into an objective science

We offer a range of services from traditional histopathology techniques to advanced digital pathology, whole slide scanning and development of image analysis algorithms

Transforming pathology into an objective science

At the heart of science – your trusted diagnostics partner

We work with scientists from pharmaceutical, biotech, CRO, companion diagnostics and healthcare industries

At the heart of science – your trusted diagnostics partner

Cutting edge innovation

We offer a range of services from traditional histopathology techniques to advanced digital pathology, whole slide scanning and development of image analysis algorithms

Cutting edge innovation

Pathology Diagnostics Ltd is an independent GCLP accredited histopathology research organisation delivering high-quality tissue laboratory & diagnostics services to industry Research & Development scientists engaged in drug and biomarker development.

Since our establishment, we have achieved the following recognition:

  • 2013 EU FP7 Grant Winner, European consortium Cancer biomarker discovery & validation
  • 2012 TSB Biomedical Catalyst Award winner
  • 2011 Cambridgeshire/EEDA High Growth Coaching Scheme Award
  • 2010 Finalist, UK Medilink Awards
  • 2009 Winner, ERBI Best Biotech/Medtech Start-up Award
  • 2008 Winner, EW Eastern Region Innovation/Science & Technology Award

At Pathology Diagnostics Ltd we realise that our clients’ satisfaction is paramount. A selection of real feedback from our clients:

The experience and capabilities of the staff at Pathology Diagnostics Ltd, were judged to be more than up to the task. We appreciate your efforts and look forward to working with you again

If you would like further information, please contact us.

Latest Blog

Feb
2015

February 2015: Highlights of the 10th Annual Biomarkers Congress, Manchester, UK: latest pharma industry news

more >

Latest News

Jul
2015

NATURE Publication: Breakthrough Development in Cancer Diagnostics: new in vivo biomarker linked fluorescent probes for fluorescent colonoscopy

more >

Apr
2015

Pathology Diagnostics Ltd. presents at Cambridge business seminar on Managing Change

more >

Events

23 Jun
2015

Dublin Pathology 2015 Dublin Ireland

more >

Publications

July
2015

Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met July 2015 Nature Medicine (2015) doi:10.1038/nm.3641

more >

#UK #healthnews for #doctors: new guidelines for care of the dying adult in #NHS from #NICE http://t.co/kU87nPO7Um

#UK #healthnews for #doctors: new guidelines for diagnosis and treatment of #melanoma in NHS published by #NICE http://t.co/3DpDZqx8xG

Role of #genes in disease revealed in major European study by EUMODIC IMPC consortium published in Nature Genetics http://t.co/RFlzZk25dF

#health economic news: #pharma firms underinvest in long-term #cancer therapy #clinicaltrials http://t.co/utEUYhcrrp

#Science #research news: Yale study identifies 'major player' in skin #cancer genes: NF1 lost in 45% of #melanoma http://t.co/9X9XAEyCPU